Pharmacotherapy of insomnia: Practice and prospects
- 1 May 1995
- journal article
- review article
- Published by Springer Nature in Pharmacy World & Science
- Vol. 17 (3) , 67-75
- https://doi.org/10.1007/bf01875434
Abstract
Insomnia is a complex complaint which is often multifactorial in origin. Pharmacotherapy can only be an adjunct in the treatment of insomnia and hypnotics should be given on an intermittent basis for short periods of time. An overview is presented of the currently available hypnotics, of which benzodiazepines are still the most widely prescribed. New drugs which bind to specific receptor subtypes or which are partial benzodiazepine receptor agonists might overcome the disadvantages associated with chronic benzodiazepine use, but more longterm investigations are needed.Keywords
This publication has 111 references indexed in Scilit:
- Replacement of Benzodiazepines with ???Old-Fashioned??? HypnoticsDrug Safety, 1993
- Prescribing Short-Acting HypnosedativesDrug Safety, 1992
- Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the ElderlyClinical Pharmacokinetics, 1991
- ZolpidemDrugs, 1990
- Formation of Active Metabolites of Psychotropic DrugsClinical Pharmacokinetics, 1990
- Melatonin stabilises sleep onset time in a blind man without entrainment of cortisol or temperature rhythmsNeuroscience Letters, 1990
- QuazepamDrugs, 1988
- Effect of Gradual Withdrawal on the Rebound Sleep Disorder after Discontinuation of TriazolamNew England Journal of Medicine, 1987
- HypnoticsDrugs, 1986
- Clinical Evaluation of Hypnotic Drugs: Contributions from Sleep Laboratory StudiesThe Journal of Clinical Pharmacology, 1979